Malaysian aviation regulators have cleared the merger between Korean Air and Asiana Airlines, becoming the latest in a growing list of regulators around the world to grant approval.
In a final decision released on September 9, the Malaysian Aviation Commission (Mavcom) reiterated the point that the merger would not infringe local competition laws, and was unlikely to have “any unilateral effects or act as a barrier to entry and expansion for the related markets.”
It also accepted Asiana’s “failing firm defense,” in which it notes that the Star Alliance carrier was struggling financially, and “cannot be rehabilitated but for the anticipated merger.”
Mavcom scoped its analysis to one route between Malaysia and South Korea — Seoul-Kota Kinabalu — given that both Korean Air sister company Jin Air and Asiana low-cost arm Air Seoul operate the route. Jeju Air, which is unaffiliated to the merger, is the third carrier to fly between both cities.
Mavcom’s decision — the first competition-related merger case reviewed by a Malaysian regulator — means Korean Air is one step closer to completing the merger with its compatriot and one-time rival Asiana.
Korean Air announced it was acquiring Asiana in November 2020, amid the coronavirus pandemic which had battered the country’s airline sector.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Top Antitrust Expert Joins Cravath from Paul Weiss
Jan 21, 2025 by
CPI
CMA Chief Removed as UK Government Targets Regulatory Overhaul
Jan 21, 2025 by
CPI
Court Denies Dismissal in Crab Price-Fixing Lawsuit
Jan 21, 2025 by
CPI
TikTok Stays Online for Now: Trump Floats US Ownership Deal
Jan 21, 2025 by
CPI
Hong Kong Watchdog Unveils Compliance Tool for Small Businesses
Jan 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan